# Iquum, Inc.

- Location (FDA's records): Marlborough, MA
- FDA decisions: 3 (2011–2016): 3 510(k) clearances
- Product codes: OCC (2), PGX (1)
- Predicates its devices cite: 8 (1 its own); citations of its devices by later devices: 9 (1 its own)
- Recalls linked to its devices: 4 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Prodesse, Inc.: 3 (https://510kreport.com/company/prodesse)
- Gen-Probe Prodesse, Inc.: 2 (https://510kreport.com/company/gen-probe-prodesse)
- Cepheid: 1 (https://510kreport.com/company/cepheid)
- Quidel Corp.: 1 (https://510kreport.com/company/quidel)

## Firms that cite its devices most
- Roche Molecular Systems, Inc.: 3 (https://510kreport.com/company/roche-molecular-systems)
- Cepheid: 2 (https://510kreport.com/company/cepheid)
- Mesa Biotech, Inc.: 1 (https://510kreport.com/company/mesa-biotech)
- Luminex Corporation: 1 (https://510kreport.com/company/luminex)
- Alere Scarborough, Inc D/B/A Binax, Inc.: 1 (https://510kreport.com/company/alere-scarborough-d-b-a-binax)

## Its most-cited devices
- K141338: Liat Strep a Assay (2014), cited by 5
- K111387: Liat (TM) Influenza a / B Assay, Liat (TM) Analyzer (2011), cited by 3
- K153544: cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System (2016), cited by 1

## Recent decisions
- K153544: cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System (Jul 25, 2016)
- K141338: Liat Strep a Assay (Nov 4, 2014)
- K111387: Liat (TM) Influenza a / B Assay, Liat (TM) Analyzer (Aug 4, 2011)

Source page: https://510kreport.com/company/iquum